205 related articles for article (PubMed ID: 35498417)
1. Correlation Between Circulating PCSK9 Levels and Gestational Diabetes Mellitus in a Chinese Population.
Wu Y; Shi J; Su Q; Yang Z; Qin L
Front Endocrinol (Lausanne); 2022; 13():826757. PubMed ID: 35498417
[TBL] [Abstract][Full Text] [Related]
2. Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population.
Guo W; Gong Y; Gu Y; Fu Z; Fan H; Gao B; Zhu X; Fu J; Zhao Y; Sun M; Liu X; Jiang XC; Yang T; Zhou H
Lipids Health Dis; 2018 Jan; 17(1):15. PubMed ID: 29343301
[TBL] [Abstract][Full Text] [Related]
3. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
Li JY; Wu GM; Hou Z; Cao YM
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
[TBL] [Abstract][Full Text] [Related]
4. Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study.
Shi J; Zhang W; Niu Y; Lin N; Li X; Zhang H; Hu R; Ning G; Fan J; Qin L; Su Q; Yang Z
Cardiovasc Diabetol; 2020 Dec; 19(1):209. PubMed ID: 33302966
[TBL] [Abstract][Full Text] [Related]
5. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
[TBL] [Abstract][Full Text] [Related]
6. Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI.
Wild RA; Weedin E; Cox K; Zhao YD; Wrenn DS; Lopez D; Wooten CJ; Melendez QM; Myers D; Hansen KR
J Clin Lipidol; 2022; 16(4):483-490. PubMed ID: 35717446
[TBL] [Abstract][Full Text] [Related]
7. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance.
Benhalima K; Van Crombrugge P; Moyson C; Verhaeghe J; Vandeginste S; Verlaenen H; Vercammen C; Maes T; Dufraimont E; De Block C; Jacquemyn Y; Mekahli F; De Clippel K; Van Den Bruel A; Loccufier A; Laenen A; Minschart C; Devlieger R; Mathieu C
Diabetologia; 2019 Nov; 62(11):2118-2128. PubMed ID: 31338546
[TBL] [Abstract][Full Text] [Related]
9. Positive correlation of plasma PCSK9 levels with HbA1c in patients with type 2 diabetes.
Yang SH; Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Cui CJ; Sun J; Li JJ
Diabetes Metab Res Rev; 2016 Feb; 32(2):193-9. PubMed ID: 26377225
[TBL] [Abstract][Full Text] [Related]
10. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study.
Brouwers MC; Troutt JS; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schaper NC; Schalkwijk CG; Konrad RJ; Stehouwer CD
Atherosclerosis; 2011 Jul; 217(1):263-7. PubMed ID: 21497351
[TBL] [Abstract][Full Text] [Related]
11. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.
Simonen P; Stenman UH; Gylling H
Clin Sci (Lond); 2015 Sep; 129(5):439-46. PubMed ID: 25857271
[TBL] [Abstract][Full Text] [Related]
12. Association of circulating CEACAM1 levels and insulin sensitivity in gestational diabetes mellitus.
Wu Y; Yang Z; Zhu L; Su Q; Qin L
BMC Endocr Disord; 2020 May; 20(1):66. PubMed ID: 32414367
[TBL] [Abstract][Full Text] [Related]
13. Association of serum lipid peroxidation and glutathione peroxidase 4 levels with clinical outcomes and metabolic abnormalities among patients with gestational diabetes mellitus: a case-control study in the Chinese population.
Zhang B; Zhang T; Hu S; Sun L
Front Biosci (Landmark Ed); 2022 Feb; 27(2):68. PubMed ID: 35227011
[TBL] [Abstract][Full Text] [Related]
14. Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels and Cardiometabolic Risk Factors: A Population-Based Cohort Study.
Shi J; Li X; Zhang W; Niu Y; Lin N; Zhang H; Ning G; Fan J; Qin L; Su Q; Yang Z
Front Cardiovasc Med; 2021; 8():664583. PubMed ID: 34041285
[No Abstract] [Full Text] [Related]
15. Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population.
Hamamura H; Adachi H; Enomoto M; Fukami A; Nakamura S; Nohara Y; Morikawa N; Sakaue A; Toyomasu K; Yamamoto M; Fukumoto Y
J Atheroscler Thromb; 2021 Apr; 28(4):329-337. PubMed ID: 32624555
[TBL] [Abstract][Full Text] [Related]
16. Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication.
Furuhashi M; Omori A; Matsumoto M; Kataoka Y; Tanaka M; Moniwa N; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
Am J Cardiol; 2016 Jul; 118(2):198-203. PubMed ID: 27241838
[TBL] [Abstract][Full Text] [Related]
17. HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".
Kohli P; Ganz P; Ma Y; Scherzer R; Hur S; Weigel B; Grunfeld C; Deeks S; Wasserman S; Scott R; Hsue PY
J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130349
[TBL] [Abstract][Full Text] [Related]
18. Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes.
Tricò D; Raggi F; Distaso M; Ferrannini E; Solini A
Diabetes Res Clin Pract; 2022 Aug; 190():109983. PubMed ID: 35803317
[TBL] [Abstract][Full Text] [Related]
19. Circulating PCSK9 levels correlate with the serum LDL cholesterol level in newborn infants.
Araki S; Suga S; Miyake F; Ichikawa S; Kinjo T; Yamamoto Y; Kusuhara K
Early Hum Dev; 2014 Oct; 90(10):607-11. PubMed ID: 25134067
[TBL] [Abstract][Full Text] [Related]
20. Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control.
Bojanin D; Vekic J; Milenkovic T; Vukovic R; Zeljkovic A; Stefanovic A; Janac J; Ivanisevic J; Mitrovic K; Miljkovic M; Spasojevic-Kalimanovska V
Atherosclerosis; 2019 Jan; 280():14-20. PubMed ID: 30453116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
